DXIV - ETF AI Analysis
Top Page
Dimensional International Vector Equity ETF (DXIV)
Rating:62Neutral
Price Target:―
Positive Factors
Broad International Diversification
The fund spreads its investments across many countries, with meaningful exposure to Japan, the UK, Europe, Canada, and others, which helps reduce reliance on any single market.
Balanced Sector Mix
Holdings are spread across industrials, financials, materials, consumer sectors, energy, technology, and health care, helping to limit the impact of weakness in any one industry.
Solid Recent Performance from Key Holdings
Several of the top positions, including major technology, materials, and health care names, have shown strong gains this year, supporting the ETF’s recent performance.
Negative Factors
Higher Expense Ratio Than Some Broad ETFs
The fund’s fee level is moderate rather than rock-bottom, so cost-conscious investors could find cheaper options in plain-vanilla international index funds.
Small Position Sizes in Top Holdings
Each individual top holding makes up less than a single percent of the portfolio, which can dilute the impact of even strong-performing stocks on overall returns.
Exposure to Lagging Stocks
A few notable holdings, such as some large energy and pharmaceutical names, have shown weak performance this year, which can drag on the fund’s results if the trend continues.
DXIV vs. SPDR S&P 500 ETF (SPY)
AUM147.62M
RegionDeveloped Markets
Expense Ratio0.30%
Beta0.67
IssuerDimensional
Inception DateSep 12, 2024
Dividend Yield2.33%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume8,011
30 Day Avg. Volume11,946
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
80.19Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering2553
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
DXIV Summary
Dimensional International Vector Equity ETF (DXIV) is an international stock fund that invests in companies outside the U.S., without tracking a specific index but following Dimensional’s global equity strategy. It spreads money across many countries like Japan, the UK, and Canada, and across sectors such as industrials, financials, and materials. Well-known holdings include Novartis and ASML. Someone might invest in DXIV to diversify beyond U.S. stocks and seek long-term growth from both developed and emerging markets. A key risk is that international stocks can be volatile and move up or down with global markets and currency swings.
How much will it cost me?The Dimensional International Vector Equity ETF (DXIV) has an expense ratio of 0.3%, which means you’ll pay $3 per year for every $1,000 invested. This cost is slightly higher than average for ETFs because it is actively managed, focusing on a refined selection of international stocks to enhance potential returns.
What would affect this ETF?DXIV's focus on developed markets outside the U.S. and its exposure to sectors like Industrials, Financials, and Consumer Cyclical could benefit from global economic growth and increased infrastructure spending. However, challenges such as rising interest rates, geopolitical tensions, or regulatory changes in key regions could negatively impact its performance. The ETF's top holdings in energy and healthcare companies may also be influenced by fluctuating commodity prices and evolving healthcare policies.
DXIV Top 10 Holdings
DXIV leans heavily into developed markets outside the U.S., and its story right now is all about old-world energy and industrial muscle rather than flashy tech. Suncor, Shell, and TotalEnergies are doing the heavy lifting, with rising share prices giving the fund a solid boost. ASML adds a powerful semiconductor angle, though its recent trading has been a bit mixed after a strong run. On the softer side, defensive names like Novartis and Bayer have been lagging, acting more like a brake than an engine for performance.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| TotalEnergies SE | 1.13% | $1.66M | €168.14B | 60.33% | 78 Outperform | |
| BHP Group Ltd | 0.76% | $1.12M | AU$274.26B | 84.04% | 68 Neutral | |
| Novartis | 0.74% | $1.09M | $280.58B | 43.28% | 80 Outperform | |
| ASML Holding | 0.72% | $1.05M | $566.94B | 121.03% | 81 Outperform | |
| Shell | 0.63% | $933.13K | $256.97B | 48.51% | 78 Outperform | |
| ORANGE SA | 0.61% | $901.37K | €47.71B | 47.36% | 65 Neutral | |
| Suncor Energy | 0.59% | $874.78K | $76.44B | 92.62% | 77 Outperform | |
| AstraZeneca | 0.58% | $847.21K | $316.55B | 52.18% | 80 Outperform | |
| Bayer | 0.55% | $804.39K | €39.41B | 100.63% | 54 Neutral | |
| Roche Holding AG | 0.53% | $774.37K | $318.75B | 31.82% | 73 Outperform |
DXIV Technical Analysis
Positive
―
Price Trends
69.33
Positive
66.93
Positive
63.24
Positive
Market Momentum
0.35
Negative
63.04
Neutral
94.61
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DXIV, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 67.62, equal to the 50-day MA of 69.33, and equal to the 200-day MA of 63.24, indicating a bullish trend. The MACD of 0.35 indicates Negative momentum. The RSI at 63.04 is Neutral, neither overbought nor oversold. The STOCH value of 94.61 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DXIV.
DXIV Peer Comparison
Comparison Results
Performance Comparison
DXIV
Dimensional International Vector Equity ETF
70.88
21.38
43.19%
SEIE
SEI Select International Equity ETF
―
―
―
FYLD
Cambria Foreign Shareholder Yield ETF
―
―
―
AVSD
Avantis Responsible International Equity ETF
―
―
―
TXUE
Thornburg International Equity ETF
―
―
―
RFDI
First Trust Riverfront Dynamic Developed International ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents